Viewing Study NCT04785833


Ignite Creation Date: 2025-12-25 @ 2:46 AM
Ignite Modification Date: 2025-12-29 @ 12:44 AM
Study NCT ID: NCT04785833
Status: UNKNOWN
Last Update Posted: 2021-03-08
First Post: 2021-03-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: CD7 CAR-T in the Treatment of CD7 Positive Refractory Relapsed Acute Leukemia
Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-03-04
Start Date Type: ESTIMATED
Primary Completion Date: 2022-04-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-02-04
Completion Date Type: ESTIMATED
First Submit Date: 2021-03-03
First Submit QC Date: None
Study First Post Date: 2021-03-08
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-03-03
Last Update Post Date: 2021-03-08
Last Update Post Date Type: ACTUAL